We determined the direct cost of an Intensive Care Unit (ICU) bed in a tertiary referral Australian ICU and the cost drivers thereof, by retrospectively analysing a number of prospectively designed Hospital-and Unit-specific electronic databases. The study period was a financial year, from 1 July 2002 to 30 June 2003. There were 1615 patients occupying 5692 fractional occupied bed days at a total cost of A$15,915,964, with an average length of stay of 3.69 days (range 0.5-77, median 1.06, interquartile range 2.33). The main cost driver not incorporated into this analysis was blood products (paid for centrally). The average costs of an ICU day and total stay per patient were A$2670 and A$9852 respectively. Staff-related charges were 68.76%, with consumables related expenditure making up 19.65%, clinical support services 9.55% and capital equipment 2.04%. Overtime charges and nursing agency staff were 19.4% of staff-related charges (2.9% for agency staff), 3.9% lower than expenditure associated with full-time employment charges, such as pension and leave. The emergency nature of ICU means it is difficult to accurately set a nursing establishment to cater for all admissions and therefore it is hard to decide what is an acceptable percentage difference between agency/overtime costs compared with the costs associated with full-time staff appointments. Consumable expenditure is likely to increase the most with new innovation and therapies. Using protocol driven practices may tighten and control costs incurred in ICU.
Economic pressures are important considerations when dealing with critically ill patients and managing intensive care units. The intensivist has to balance the State Government's restrictions on expenditure with the consumer demand for an increasing number and range of expensive treatments. There have been several attempts to carry out economic evaluations of critical care using a range of methodologies [1] [2] [3] . Gyldmark in a review of the ICU cost literature in 1995 showed that the various studies used very different methods to obtain costs. As a result, she concluded that one could not compare the results of the different studies conducted in different institutions 4 .
There is little Australian data to refer to when considering ICU costs. McKinley studied 20 public adult ICUs, involving 7619 patients. She used diagnosisrelated groups, then calculated a service weight for the different diagnosis-related groups (DRGs) in intensive care patients, which gave an overall average cost per day of an ICU bed 5 . Diagnosis-related groups are a patient classification scheme used by the Federal government. They provide a means of relating patient diagnosis to the costs incurred by the hospital, and are the basis for Medicare's hospital reimbursement system. Diagnosis-related group definitions are published in the Federal Register 6 . McKinley found the overall average daily cost for a public adult ICU bed in Australia in 1997 to be A$1605 5 . She did not include clinical support services and expressed concern regarding quality of data provided by participating units due to lack of resources, which may have affected the service weighting. In addition, some DRGs contained few patients, making the costs for these groups less reliable.
Another methodology was used in a recent study by Moran et al 7 , whose main aim was to assess the ability of specific scoring systems (TISS and OMEGA) along with other factors (cumulative daily severity of illness and ventilation days) to predict costs. Moran's group used results from a 1991 South Australian Health Care Commission study, in which dedicated data collectors recorded daily activities and costs over nine months to form a "ground-up" evaluation of ICU costs. They applied calculated cost increases to predict 2002 ICU costs, the latter requiring significant statistical processing. They estimated a cost of A$2395 per occupied bed day (OBD). Data collection using this method is very labour intensive unless specific systems to collect TISS and OMEGA are prospectively set up.
The European Society of Intensive Care Medicine (ESICM) set up a Health Services Research and Outcome Working Group on Cost Effectiveness in 2001. They recommended that when undertaking a study to measure costs, it is important to state: (a) the aim of the cost assessment study; (b) the perspective (point of view); (c) the type of costs that need to be measured; and (d) the time span of assessment. By being explicit about the rationale of the study and the methods used, it is hoped that the results of economic evaluations will be reproducible 8 . Edbrooke, who was part of the ESICM Working Group, set up a program named the "International Program for the resOurce use in Critical care" (IPOC) 9 . He divided costs into four main groups (namely staff, clinical support services (radiology and laboratory), disposables (drugs, blood, etc) and capital equipment). The Economies of Scale in British ICUs study used this methodology. They noted average costs of £995 per day (A$2388, exchange £1=A$2.40), but demonstrated that the bigger the unit the less expensive it was 10 .
The emergence of new and expensive therapies, such as activated Protein C 11 , and demands for an improved evidence base, make it increasingly necessary to be able to cost intensive care services. Attempts have been made to control costs in intensive care. A focus on quality improvement in the ICU has been shown to have a beneficial impact on outcome and simultaneously reduce costs 12 . Another approach has been to inform physicians on a daily basis of the cost of individual tests, which can reduce costs 13 , although this approach may not be welcome in all ICUs.
The aim of the present paper was to investigate cost per OBD in a tertiary ICU and to document our cost drivers. We wished to identify areas of high cost and possible ways of controlling or even reducing them. This was done using the "ground-up" methodology, which involves identifying then summing all costs. The reverse of this is a "top-down" methodology, which starts at the total expenditure, then breaks down costs. We followed criteria set out by the ESICM Health Services Research and Outcome Working Group on Cost Effectiveness 8 .
METHODS
Research ethics committee approval was sought but considered unnecessary. The Royal Brisbane and Women's Hospital is a 942 bed tertiary hospital for a local population of greater than 500,000 people in Queensland, Australia 14 . The hospital is a referral centre catering for most disciplines, including bone marrow transplantation, burns and neurosurgery. There is no solid organ transplantation performed at the hospital. The ICU consists of 15 ventilator capable beds and four high dependency unit (HDU) beds and it is a closed unit admitting medical and surgical patients (excluding cardiac surgery and paediatrics). HDU provides an intermediate level of clinical care between a general ward and the ventilator capable part of the ICU and can be a "step up" or "step down" between the two. HDU provides invasive monitoring for patients with, or at risk of developing, acute (or acute on chronic) single organ failure 15 .
The ICU has a 24-hour, seven days a week access (on call out of hours) to an intensivist working in ICU. There are five full time intensivists, five senior registrars (Fellows) and ten registrars/residents. The nursing staffing is in accordance with Australian College of Critical Care Nurses (ACCCN) standards and in essence consist of 5.2 Full Time Equivalents (FTE) per ventilated bed (with extra "access" nurses bringing the actual total up to over six per ventilated bed) and half that for the HDU patients.
The study period was the financial year from 1 July 2002 to 30 June 2003 and involved a retrospective review of prospectively collected data from the ICU Clinical Information System (CIS) (CareVue®, Phillips Medical Systems, Best, The Netherlands) and the Hospital Based Clinical Information System (HBCIS). CareVue ® is a computerized system that operates separate from all other hospital computer networks 16 . The HBCIS is used to register, transfer and discharge patients. A variety of reports are obtained from HBCIS and are used for an ongoing prospectively collected monthly ICU Budget Report, namely a) Bed utilization statistics by ward (ICU total occupied bed days based on a daily midnight census including HDU), giving a point prevalence dataset, b) Statistics summary report by unit (the HDU and ventilator capable total occupied bed days (OBDs) and discharges to calculate the average length of stay), giving a 24-hour bed capability/occupancy, and c) Patients treated within ICU for a specific date range, giving a specific time period. This provides length of stay and OBD.
In accordance with the European Society of Intensive Care Medicine Working Group on Cost Effectiveness in ICU, we conducted our study based on their four suggested criteria 8 . The aim of the study was to calculate the actual average cost of an ICU bed per day and determine the contributors towards the costs. Once the cost drivers were known, we wished to find out ways of improving efficiency and try and identify high cost items. We grouped the types of costs into a) Staff costs-labour cost of all medical and nursing staff, b) Clinical support services-radiology and laboratory services, c) Disposables-drugs, blood, etc and d) Capital equipment. The time span of the assessment in our study was one financial year. Pathology and radiology charge a set fee for an investigation or test and these charges do not include any overhead charges.
Patients
Diagnostic breakdown into medical specialty, source of admission, APACHE II and SAPS II information was obtained from CareVue ®. Patient activity, length of stay and costing information was obtained using HBCIS, which is the system upon which budgeting is determined.
Data Acquisition for the ICU Budget Report
Most of the data in the budget report is copied and pasted from information systems, e.g. HBCIS and Decision Support System (DSS) Fammis Accrual ledger (includes ledger module, payroll model and Human Resource module). A division of the Hospital's Finance Department helps coordinate this process and with senior ICU staff input, a monthly report is produced. Some of the data in the ICU budget report includes formulae e.g. cost/OBD, number of public pathology tests/OBD. The DSS is a system which includes all budgets, expenditure and revenue for all cost centres/trust funds by account code (e.g. medical labour) and by District (e.g. Royal Brisbane and Women's Health Service District) for Queensland Health. Data can be viewed by month or financial year-to-date. DSS Pathology is another system, which includes pathology data such as the number of tests and cost per test by cost centre. DSS Payroll Full Time Equivalents (FTE) is a system that feeds into Fammis Accrual for labour payments. From this one is able to see dollar amounts paid to employees and FTEs by fortnight, month and financial year for each cost centre. There is an ability to "drill down" to individual employees to ascertain payments in each two-week interval and break down into penalties, overtime etc. Human Resource DSS allows us to analyse sick leave trends by employee groups (e.g. technicians) vs district, zonal and Queensland health averages etc. CareVue ® gives information on average length of stays (ALOS), fractional bed days, APACHE II scores and readmissions that are used for the budget report.
Economic Evaluation
The budget report for the financial year 1 July 2002 to 30 June 2003, which was provided by the hospital finance department, was evaluated. Labour costs, which included all permanent and temporary staff members and their salary benefits, medical imaging, drugs, clinical supplies and pathology costs were reviewed from the report. We looked at the breakdown of these costs and determined percentages of the total costs. Excluded were the costs incurred for consultations from visiting medical teams and the resources used when patients went to the operating theatre. In addition no blood products are paid for by the ICU, but are instead centrally funded through the Australian Red Cross. Allied health specialties and hospital overheads such as infrastructure were excluded, as were the costs that were incurred in the emergency department and other wards when the patient was first admitted.
RESULTS
There were 1615 patients with an average length of stay of 3.69 days (range 0.5-77, median 1.06, interquartile range 2.33).
The ICU activity and the APACHE II and SAPS II scores are shown in Tables 1 and 2. The APACHE II and SAPS II scores for the ventilator capable beds and HDU have been presented to demonstrate the severity of patient illness. The combined APACHE II for ventilator capable beds and HDU at 15.6 (range 0-59, median 14, interquartile range 11) and SAPS II at 29.3 (range 0-103, median 25, interquartile range 21). The workload of the unit is predominantly surgical (surgical 47% and trauma 16%) with the rest being medical patients. The main sources of admission were from theatre or emergency medicine department, with 17% of patients transferred from other hospitals.
The expenditure for the ICU for the financial year 1 July 2002 to 30 June 2003 was A$15,915,964. There were 5692 fractional occupied bed days (OBDs) in the study period, making the average daily cost of an ICU bed A$2670. A fractional OBD is the number of patients occupying a bed for any part of a day, which is added up daily to give a total for the year.
Staff costs accounted for 68.76% of expenditure, with consumables related expenditure making up 19.65%, clinical support services 9.55% and capital equipment 2.04% of the total as shown in Table 3 .
Review of the breakdown of staff costs, which accounted for 68.76% of total expenditure, showed 57.3% of total staff costings went towards permanent staff salaries. Costs incurred by permanent members of staff made up 23.3% of total staff costings and these costs included factors such as annual leave expenses, long service leave, sick leave, superannuation and motor vehicle expenses. The costs for overtime and penalty costs incurred by permanent staff along with the employment of agency staff, made up 19.4% of total staff costings. Of the 19.4%, agency staff accounted for only 2.9%, overtime 5.1% and penalties for out of normal hours work 11.4%.
Consumable related expenditure is shown in Table  4 . The biggest items are clinical supplies (43.18%) and drugs (41.22%).
The breakdown of the top 10 drugs, which used up the greatest proportion of the drug budget, is shown in Table 5 . Nimodipine is the most costly drug in the ICU, with sedatives and anti-infective agents commonly occurring as items of high expense in the drug budget.
Clinical support services expenditure is demonstrated in Table 6 . These are the investigations ordered by clinicians, and roughly half are radiological and the other half laboratory based.
DISCUSSION
We have demonstrated that for a large public ter- When comparing different methodologies on costing, there are numerous issues to address. All costs should be identified and documented as far as possible to allow comparisons between different ICUs, and if possible this must be applicable to all systems and countries. The costings should be easy and simple to obtain, accurate and transparent, assure data quality, be universally applicable and stable over time. When contrasting different countries, factors such as the exchange rate and trade barriers/agreements between countries have to be considered; it must reflect purchasing power and compare costs and resources but not charges 9 .
Critical care encompasses patients with different severity of illness at any one time. Depending on at what stage a patient is with their disease, the APACHE II or SAPS II will vary. Slatyer described a mean total admission cost of A$1357 back in 1986 (Class 4 TISS mean=A$3706) but for over 70% of patients costs were less than A$1000 17 . It becomes difficult to compare units with different case mixes. The main determinants of case mix are local disease processes, referral patterns and the location of funding and services, making comparison difficult between different states and countries. We believe that the standardized approach used in our study is likely to produce reproducible outcomes.
The largest proportion of costs for health care are staff-related. Staff-related costs do not vary for patient length of stay unlike clinical expenditure, which is likely to be higher on admission. The potential for emergency admissions to ICU is high and it has been previously described that medical admission to a hospital is a high resource user 20 . The budget user needs to cover an unpredictable workload. This makes determination of permanent staff numbers difficult. If additional staff are required, this can be covered by paying permanent staff overtime or obtaining outside labour from an agency.
From our study it can be seen that salaries make up 56.5% of labour costs, but there is a further 23.2% of staff costings going towards permanent staff leave, superannuation etc. This is balanced against 19.4% of staff costings for overtime, penalties for overtime and external labour. Having a permanent member of staff at work but not working intuitively appears to be not cost effective. The penalties for overtime of 11.4% appear high and these may be reduced by ensuring shifts don't overrun. Interestingly the high penalties have been previously used by the department to obtain additional full-time medical staff. Determining the balance between paying overtime for permanent staff or agency as opposed to employing more permanent members of staff is difficult. Should the expenditure on both these groups balance out or should one be a lot greater than the other? If permanent staff don't work overtime, would the cost per OBD be less compared to a unit where there is overtime and agency staff working? The way to determine this would be to introduce an overtime ban and compare this to a time period when overtime is utilized. However this may generate staff dissatisfaction, which is dangerous, as ICU nurses are a scarce resource.
Consumables (19.65%) make up the next largest part of expenditure, with drugs and clinical supplies the biggest items. Overheads, such as repairs, telephone expenses etc are included in this. Other overheads such as electricity and water costs are not. Clinical supplies reflect how much activity is carried out on patients. If there is a short length of stay, more clinical supplies will be needed per day, with the instigation of ventilation and insertion of monitoring devices. There is little control over this, except for possibly changing monitoring devices on a clinical basis rather than a set time period. It is our routine practice to change lines after seven days. The drug expenditure is related to drug unit cost and amounts used which is determined by casemix. Sedatives take up four positions in the top ten, with antiinfective agents a further three. Activated Protein C, for example, has a very expensive unit cost and in future drug budgets this may have a big impact on expenditure. The high cost of nimodipine relates to the workload of a neurosurgical tertiary referral unit. In general a unit's referral patterns, its policies and bed availability may influence drug expenditure.
Clinical support, including medical imaging and laboratory investigation, is a large cost driver. A possible approach to reducing these is to either standardize management of certain conditions 13 or daily remind the staff ordering these investigations of the costs incurred 12 . Economy of scale in which larger units are more costs effective than smaller units is another option 10 .
Capital acquisitions run at 2.04% per year of total expenditure, which is used mainly to replace equipment that is obsolete. Repairs and maintenance make up 2.18% of total expenditure. It is essential to ensure that properly functioning equipment is available at all times. It may be argued that if all the equipment was new or under warranty, which included free repair, then repairs and maintenance would decrease with a smaller increase in capital acquisitions.
In Finland, where 20% of the hospital budget is spent in ICU, they found over a four-year period that patients with a higher severity of illness, were treated with unchanged outcome but at lower costs towards the end of the study period. They suggested that costs of intensive care are not necessarily increasing 21 . The use of average costs or scoring systems to cost intensive care is limited, as these methods cannot determine actual resource usage in individual patients 22 . In addition there are numerous problems when comparing costs with different units, but there is progress being made with the development of standardized approaches. Foreign exchange issues aside, by looking at Edbrooke's four groups, comparisons can be made 9 .
Better characterization of groups of patients would be informative and probably warrants further investigation. Our internally designed databases do not use DRGs, and hence we cannot comment on these. A more formal analysis could also be undertaken on the most expensive DRGs. Another area where useful data could be obtained is for the sickest patients that actually survive, as these would possibly consume an extraordinary proportion of the budget. Cost analysis of various TISS groupings 18 could also generate interesting data.
Our study gives an average cost for an ICU bed per OBD in Brisbane with the cost drivers involved. If repeated in the same unit, with emphasis on staff related charges and numbers of permanent staff in relation to overtime and agency staff, along with a standardized protocol approach to disease management, costs may very well be different. These are the main areas where we believe cost savings can be made.
In conclusion we have attempted to accurately cost the financial burden of our tertiary Intensive Care Unit using a "ground up" methodology. We have described our casemix, identified cost drivers and itemized much of these costs for comparative purposes. For the financial year 2002/2003 the expenditure for the ICU was A$15,915,964. This translated into the cost of an OBD of $2670.
